Latest Movers & Shakers in ICU

The Vienna-based pharmaceutical company AOP Orphan Pharmaceuticals GmbH (AOP Health), which specializes in rare diseases and critical care medicine ,  is repositioning itself strategically. In order to offer patients and healthcare professionals state-of-the-art therapy concepts not only today

Essentia Health-Fargo is proud to welcome Dr. Shu Xian (Suzanne) Lee, who specializes in critical care.   “I was drawn to practice at Essentia Health because of the camaraderie I witnessed amongst the staff, and I felt very welcomed to the community,” said Dr. Lee. “I do not have persona

Xencor, Inc., a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases announced the appointment of Barbara J. Klencke, M.D., to its board of directors. Dr. Klencke has more than 20 years of bio

Getinge announces that Jeanette Hedén Carlsson has decided to resign after 6 years as Executive Vice President, Brand & Communication, and member of the Executive Team. The process to recruit a successor will start immediately.   ”Jeanette has successfully built and developed effecti

Robert Möller appointed to the Fresenius Management Board; at the same time, Möller will assume responsibility for hospital group as CEO of Helios Health GmbH  Dr. Francesco De Meo leaves the company  Management Board team continues to drive froward transformation on the way to #

The Vienna native has a wealth of experience in pharma and will be building up the European pioneer’s area of Patient Advocacy in the field of rare diseases and intensive care.   As of June 2023, Marion Rottenberg has taken over the role of International Patient Advocacy Lead at AOP Heal

George Goshua, MD, MSc, Assistant Professor of Medicine (Hematology) within the Classical Hematology Program at Smilow Cancer Hospital and Yale Cancer Center, has been invited to join the  Annals of Internal Medicine  Editorial Board for a 3-year term, effective July 1, 2023. Established

Ramon W. Johnson, M.D., M.B.A., is the new President of the American Board of Emergency Medicine (ABEM). Dr. Johnson has been an oral examiner since 1993 and has been a member of the Board of Directors since July 2015. He has served ABEM in a number of capacities, including as a Chief Examiner for

Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases has appointed Martin Fischer (46) as Chief Financial Officer as of October 1, 2023. He will succeed Helen Giza who was appointed as Chief Executive Officer and Chair of the Management B

Biopharma executive with more than 20 years of global corporate, business development, and commercial strategy experience to join Replicate leadership team   Replicate Bioscience, a company pioneering novel self-replicating RNA (srRNA) technology for use in infectious disease, oncology,